Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
1-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.3.4
advertisement
11.3.4 Betablocker
(13)
Showing records 1 to 13
Display all abstracts in classification
11.3.4 Betablocker
Search within classification 11.3.4 Betablocker
15426
Ocular pulse amplitude, intraocular pressure and beta-blocker/carbonic anhydrase combination therapy
Schmidt KG; Von Rückmann A; Becker R; Pillunat LE
Klinische Monatsblätter für Augenheilkunde
1999; 215: 361-366
15450
Beta-blocker eyedrops and nocturnal arterial hypotension
Hayreh SS; Podhajsky P; Zimmerman MB
American Journal of Ophthalmology
1999; 128: 301-309
15501
The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life
Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I; United States Patient Preference Study Group; International Patient Preference Study Group
Journal of Glaucoma
1999; 8: 315-324
15503
A case of drug-induced limbal dysfunction due to antiglaucoma eyedrops
Noda K; Konishi M; Yamada M; Tanino T; Mashima Y
Folia Ophthalmologica Japonica / Nihon Ganka Kiyo
1999; 50: 667-670
15508
Central nervous system and plasma lipid profiles associated with carteolol and timolol in postmenopausal black women
Bartlett JD; Olivier M; Richardson T; Whitaker R Jr; Pensyl D; Wilson MR
Journal of Glaucoma
1999; 8: 388-395
15509
Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol
Evans DW; Harris A; Cantor LB
Journal of Ocular Pharmacology and Therapeutics
1999; 15: 479-487
15510
Comparison of 24 hour control with Timoptic(TM) 0.5% and Timoptic-XE(TM) 0.5% in exfoliation and primary open-angle glaucoma
Konstas AGP; Mantziris DA; Maltezos A; Cate EA; Stewart WC
Acta Ophthalmologica Scandinavica
1999; 77: 541-543
15511
Betaxolol, a beta
1
-adrenoceptor antagonist, has an affinity for L-type Ca sup(2+) channels
Melena J; Wood JPM; Osborne NN
European Journal of Pharmacology
1999; 378: 317-322
15512
Alpha-1-adrenoceptor blocking activity of KT-210 Inipradilol ophthalmic solution) on intraocular pressure in the rabbit eye
Nishio K; Kimura T; Orihashi M; Yui M
Folia Ophthalmologica Japonica / Nihon Ganka Kiyo
1999; 50: 655-660
15513
Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
Osborne NN; DeSantis L; Bae JH; Ugarte M; Wood JPM; Nash MS; Chidlow G
Experimental Eye Research
1999; 69: 331-342
15514
Characterization of ocular pharmacokinetics of tilisolol after instillation into anesthetized rabbits
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Biological & Pharmaceutical Bulletin
1999; 22: 1253-1255
15515
Efficacy and safety of timolol solution once daily versus timolol gel added to latanoprost
Stewart WC; Day DG; Sharpe ED; Dubiner HB; Holmes KT; Stewart JA
American Journal of Ophthalmology
1999; 128: 692-696
15516
Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation
Yamamura K; Sasaki H; Nakashima M; Ichikawa M; Mukai T; Nishida K; Nakamura J
Pharmaceutical Research
1999; 16: 1596-1601
Issue
1-3
Table of Contents
Editor's Selection
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement